Illumina Acquires Helixis for $105,000,000

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    5421 Avenida Encinas Carlsbad, CA 92008
  • Company Description
    Diagnostics tools for molecular analysis are critical to modern life science and medicine, but are still primitive in form and function. Helixis is developing an entirely new class of advanced molecular diagnostic products that will bring fast, accurate and low cost diagnostics to a range of critical medical and scientific applications in both the developed and developing worlds.

    Our technology is the result of a unique interdisciplinary collaboration between some of the world’s most respected molecular biologists and engineers at the California Institute of Technology.

  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    Illumina will acquire Helixis for $70 million in cash upfront, plus another $35 million in contingent considerations.

Trending on Xconomy